{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:34:14Z","timestamp":1789590854794,"version":"build-2803163510"},"reference-count":53,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Sickle cell disease (SCD) is a severe, inherited hemoglobin disorder characterized by chronic hemolysis, vaso-occlusive crises (VOCs), and systemic inflammation. Hydroxyurea is the standard conventional pharmacotherapy for SCD, but it has certain limitations, necessitating the need to explore other safe and effective treatment options for SCD. Ayurveda interventions offer a potential therapeutic approach complementary to conventional medicine for SCD management, with anti-inflammatory, immunomodulatory, and hematopoietic properties.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This randomized controlled trial will evaluate the efficacy and safety of an Ayurvedic therapeutic regimen as an adjunct to hydroxyurea in SCD management, assessing its impact on hematological parameters, inflammatory biomarkers, VOC frequency, and overall quality of life.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n A PROBE (Prospective, Randomized, Open-Label, Blinded End Point) study will be conducted on individuals of any gender aged 18 years or older and diagnosed with SCD (with hemoglobin S levels more than 60% and a history of at least 1 VOC per year over the past 3 y). Individuals with acute VOC or any severe infection requiring hospitalization, a history of significant comorbidities, or hematopoietic stem cell transplantation will not be considered. The study will be conducted at the All India Institute of Medical Sciences, Bhopal, India. A total of 100 participants will undergo random assignment in a 1:1 ratio to receive either an Ayurveda regimen (\n Dadimadi Ghrita<\/jats:italic>\n ,\n Punarnavadi Mandura<\/jats:italic>\n , and\n Vasaguduchyadi Kwatha<\/jats:italic>\n ) as an add-on to hydroxyurea or hydroxyurea alone for 8 months. The primary outcome will be a change in hemoglobin electrophoresis parameters (hemoglobin S, fetal hemoglobin, and adult hemoglobin) and the frequency of VOC episodes over 8 months. The secondary outcome measures include changes in the levels of proinflammatory markers (interleukin-6, interleukin-8, C-reactive protein, and transforming growth factor-\u03b2) and lactate dehydrogenase, frequency of hospitalization for VOCs and blood transfusions, and health-related quality of life (Short Form-8 Health Survey questionnaire). Safety will be evaluated by recording the incidence of adverse events and changes in liver and kidney function tests from baseline.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The recruitment of study participants was initiated on November 1, 2023. By the second week of February 2025, 83 participants had been enrolled in the study. The final study is expected to be complete by December 31, 2025. We will start the analysis of the study outcomes in February 2026, and the publication of the final results is expected by August 2026.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This randomized controlled trial protocol outlines a rigorous study design aimed to explore the potential benefits of an integrated therapeutic regimen comprising Ayurveda interventions and standard conventional care in the long-term management of SCD through validated clinical and laboratory parameters. The outcomes of this study can address the needs and challenges associated with SCD management and inform future management protocols.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/79603","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:52:00Z","timestamp":1777481520000},"page":"e79603-e79603","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Ayurveda Regimen as an Adjunct to Hydroxyurea in Sickle Cell Disease: Protocol for a Prospective, Randomized, Open-Label, Blinded End Point Exploratory Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-9949","authenticated-orcid":false,"given":"Danish","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-5933","authenticated-orcid":false,"given":"Amit Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4659-5224","authenticated-orcid":false,"given":"Sachin","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9827-4119","authenticated-orcid":false,"given":"Babita","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1597-5874","authenticated-orcid":false,"given":"Manisha","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-8115","authenticated-orcid":false,"given":"Garima","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-2947","authenticated-orcid":false,"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-2378","authenticated-orcid":false,"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-0050","authenticated-orcid":false,"given":"Azeem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-4900","authenticated-orcid":false,"given":"Richa","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-7026","authenticated-orcid":false,"given":"Bhagwan S","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-3531","authenticated-orcid":false,"given":"Anil","family":"Mangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-3225","authenticated-orcid":false,"given":"Bhogavalli","family":"Chandrasekhararao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3976-4978","authenticated-orcid":false,"given":"Narayanam","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4413-1937","authenticated-orcid":false,"given":"Rabinarayan","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"5","key":"R1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000540149","article-title":"Sickle cell disease","volume":"51","author":"Kunz","journal-title":"Transfus Med Hemother"},{"issue":"38","key":"R2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020020","article-title":"Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment","volume":"5","author":"Inusa","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","journal-title":"J Clin Invest"},{"issue":"16","key":"R5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","journal-title":"N Engl J Med"},{"issue":"10","key":"R6","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1097\/MS9.0000000000002551","article-title":"Potassium dynamics in sickle cell anemia: clinical implications and pathophysiological insights","volume":"86","author":"Obeagu","journal-title":"Ann Med Surg (Lond)"},{"issue":"8","key":"R7","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators","journal-title":"Lancet Haematol"},{"issue":"9861","key":"R8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","journal-title":"Lancet"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2024.101678","article-title":"Prevalence of sickle cell disease, sickle cell trait and HBS-beta-thalassemia in India: a systematic review and meta-analysis","volume":"28","author":"Rao","journal-title":"Clin Epidemiol Glob Health"},{"issue":"11","key":"R10","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.18203\/2394-6040.ijcmph20243320","article-title":"Sickle cell disease burden among tribal population of India: a narrative review","volume":"11","author":"Nagisetty","journal-title":"Int J Community Med Public Health"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4103\/0971-5916.159492","article-title":"Sickle cell disease in tribal populations in India","volume":"141","author":"Colah","journal-title":"Indian J Med Res"},{"issue":"11","key":"R12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","journal-title":"Expert Opin Drug Saf"},{"issue":"21","key":"R13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216404","article-title":"The current role of hydroxyurea in the treatment of sickle cell anemia","volume":"13","author":"L\u00f3pez Rubio","journal-title":"J Clin Med"},{"issue":"9","key":"R14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202.pub3","article-title":"Hydroxyurea (hydroxycarbamide) for Sickle cell disease","volume":"9","author":"Rankine-Mullings","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"R15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/ehm.10.22","article-title":"Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities","volume":"3","author":"Brandow","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-017-1812-2","article-title":"High prevalence of complementary and alternative medicine use among patients with sickle cell disease in a tertiary hospital in Lagos, South West, Nigeria","volume":"17","author":"Busari","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12687-022-00614-y","article-title":"Sickle cell disease-related knowledge and perceptions of traditional healers in tribal communities in India: implications on sickle cell disease programme","volume":"13","author":"Babu","journal-title":"J Community Genet"},{"issue":"9","key":"R18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291008","article-title":"Caregivers\u2019 use of herbal and conventional medicine to treat children with sickle cell disease at Jinja Regional Referral Hospital, Eastern Uganda: a cross-sectional study","volume":"18","author":"Apolot","journal-title":"PLoS One"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.39.163.20740","article-title":"Use of herbal medicine by caregivers in the management of children with sickle cell disease in Mulago National Referral Hospital - Uganda","volume":"39","author":"Lubega","journal-title":"Pan Afr Med J"},{"issue":"2","key":"R20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54060\/ijahr.2023.14","article-title":"Ayurvedic approach to sickle cell disease WSR to Sannipatika Pandu: an overview","volume":"1","author":"Bez","journal-title":"Int J Ayurveda Herbal Res"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5005\/jp-journals-10064-0001","article-title":"Clinical efficacy and safety of and in the management of iron deficiency anemia: a prospective open-label multicenter study","volume":"1","author":"Sannd","journal-title":"J Res Ayurvedic Sci"},{"issue":"Suppl 2","key":"R22","doi-asserted-by":"publisher","DOI":"10.4103\/0257-7941.123914","article-title":"PA03.17. A clinical evaluation of and in management of pandu (Iron defeciency anaemia)","volume":"32","author":"Das","journal-title":"Ancient Sci Life"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/0974-8520.153735","article-title":"A clinical study of in the management of Pandu Roga in old age (geriatric anemia)","volume":"35","author":"Pandya","journal-title":"Ayu"},{"issue":"2","key":"R24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02913329","article-title":"Scientific evaluation of some Ayurvedic preparations for correction of iron deficiency and anemia","volume":"22","author":"Sharma","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jtcme.2024.03.017","article-title":"Therapeutic efficacy of against phenylhydrazine-induced hemolytic anemia in rats","volume":"15","author":"Rajendran","journal-title":"J Tradit Complement Med"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.55718\/kja.219","article-title":"A critical review on","volume":"3","author":"Nair","journal-title":"Kerala J Ayurveda"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117935","article-title":"Indigenous wisdom of a Kwatha to treat NASH: an insight into the mechanism","volume":"326","author":"Yellurkar","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"R28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0974-7788.64405","article-title":"Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies","volume":"1","author":"Upadhyay","journal-title":"Int J Ayurveda Res"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0974-8520.141898","article-title":"Efficacy of Triphaladi Avaleha on Beejadushtijanya Pandu (thalassemia)","volume":"35","author":"Patalia","journal-title":"Ayu"},{"issue":"Suppl 2","key":"R30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.47070\/ijapr.v10iSuppl2.2554","article-title":"Clinical evaluation of T-AYU-HM premium in sickle cell anemia patients: a retrospective study","volume":"10","author":"Desai","journal-title":"Int J Ayu Pharm Res"},{"issue":"1","key":"R31","first-page":"15","volume":"17","author":"Panigrahi","journal-title":"Anc Sci Life"},{"issue":"8","key":"R32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.13040\/IJPSR.0975-8232.9(8).3573-78","article-title":"Clinical evaluation of T-AYU-HMTM in the management of sickle cell anemia","volume":"9","author":"Desai","journal-title":"Int J Pharm Sci Res"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.48165\/IRJAY.2024.70101","article-title":"A comparative clinical study to evaluate the effect of sigru leaf powder and sigru bark powder in the management of with reference to sickle cell anemia","volume":"7","author":"Bez","journal-title":"Int Res J Ayurveda Yoga"},{"issue":"1-2","key":"R34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5455\/JREIM.82-1492076751","article-title":"Sickle cell anemia: a case study","volume":"23","author":"Bhinde","journal-title":"J Res Educ Indian Med"},{"issue":"12","key":"R35","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.13040\/IJPSR.0975-8232.9(12).5522-33","article-title":"Investigation of selected herbomineral formulation T\u2011AYU\u2011H & T\u2011AYU\u2011HM","volume":"9","author":"Saraf","journal-title":"Int J Pharm Sci Res"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-12-262","article-title":", and seed oil versus glutathione, or : methanolic extracts of novel plants for the management of sickle cell anemia disease","volume":"12","author":"Afolabi","journal-title":"BMC Complement Altern Med"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1515\/jcim-2025-0238","article-title":"Efficacy of traditional medicine in the management of sickle cell disease: a scoping review of current evidence","author":"Javed","journal-title":"J Complement Integr Med"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12288-014-0409-x","article-title":"HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation","volume":"31","author":"Khera","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"R39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4274\/tjh.galenos.2023.2023.0114","article-title":"Comparison of capillary zone electrophoresis with high-pressure liquid chromatography in the evaluation of hemoglobinopathies","volume":"40","author":"\u00c7ak\u0131r Madenci","journal-title":"Turk J Haematol"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-527-5_2","article-title":"Detection and quantification of cytokines and other biomarkers","volume":"844","author":"Chiswick","journal-title":"Methods Mol Biol"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0022-1759(95)00184-c","article-title":"Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards","volume":"186","author":"Ledur","journal-title":"J Immunol Methods"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jphys.2015.07.001","article-title":"The Brief Pain Inventory (BPI)","volume":"62","author":"Poquet","journal-title":"J Physiother"},{"issue":"2","key":"R43","first-page":"129","volume":"23","author":"Cleeland","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"R44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7224\/1537-2073.2012-019","article-title":"Psychometric properties of the Modified Fatigue Impact Scale","volume":"15","author":"Larson","journal-title":"Int J MS Care"},{"issue":"3","key":"R45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.34172\/hpp.2021.43","article-title":"Psychometric properties of the Short Form-8 Health Survey (SF-8) among diabetes and non-diabetes Iranian older people","volume":"11","author":"Namjoo","journal-title":"Health Promot Perspect"},{"issue":"1","key":"R46","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0880-4","article-title":"Evaluating the reliability and validity of SF-8 with a large representative sample of urban Chinese","volume":"16","author":"Lang","journal-title":"Health Qual Life Outcomes"},{"issue":"20","key":"R47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","journal-title":"N Engl J Med"},{"key":"R48","unstructured":"National ethical guidelines for biomedical and health research involving human participants. Indian Council of Medical Research (ICMR); 2017. URL: https:\/\/ethics.ncdirindia.org\/asset\/pdf\/ICMR_National_Ethical_Guidelines.pdf [Accessed 20-04-2026]"},{"key":"R49","unstructured":"ICH Harmonised Guideline for Good Clinical Practice E6 (R3). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; Jan 6, 2025. URL: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf [Accessed 14-04-2026]"},{"issue":"9","key":"R50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004448.pub7","article-title":"Phytomedicines (medicines derived from plants) for sickle cell disease","volume":"9","author":"Oniyangi","journal-title":"Cochrane Database Syst Rev"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/808302","article-title":"Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn","volume":"2014","author":"Mishra","journal-title":"Biomed Res Int"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.39435","article-title":"Haematinic evaluation of Lauha bhasma and Mandura bhasma on HgCl-induced anemia in rats","volume":"69","author":"Sarkar","journal-title":"Indian J Pharm Sci"},{"issue":"2","key":"R53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point","volume":"1","author":"Hansson","journal-title":"Blood Press"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e79603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:12:43Z","timestamp":1782843163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e79603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":53,"URL":"https:\/\/doi.org\/10.2196\/79603","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"v15i5e79603"}}